Biomarkers and IL-2R in lung cancer.
A study of TPA, CEA and IL-2R serum levels was conducted in patients untreated with various histological types of bronchial carcinoma. A total of 43 subjects were evaluated. We have observed a significant correlation between serum levels and stage of the disease for both CEA and TPA markers, whereas for IL-2R an increase was shown for the all patients not correlated with stage.
Marino
P
P
Dipartimento di Medicina interna, Università, Ospedale S. Paolo, Milano.
Preatoni
A
A
Fonticoli
L
L
Parodi
M
M
Tarolo
G L
GL
D000230:Adenocarcinoma / Q000097:blood* / Q000473:pathology; D000368:Aged; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000097:blood* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010455:Peptides / Q000097:blood; D015375:Receptors, Interleukin-2 / Q000097:blood*; D012995:Solubility; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D015375:Receptors, Interleukin-2; D019396:Tissue Polypeptide Antigen